Hypocalcæmi I kliniske studier om osteoporose havde omkring 0, 2% af patienterne et betydeligt fald i serumcalciumniveauet (mindre end 1, 87 mmol/ l) efter administration af Aclasta.
Hypocalcaemia In clinical trials in osteoporosis, approximately 0.2% of patients had notable declines of serum calcium levels (less than 1.87 mmol/ l) following Aclasta administration.